Jim Shannon
Main Page: Jim Shannon (Democratic Unionist Party - Strangford)(12 years, 2 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The hon. Gentleman is absolutely right that the apology was fairly thin because it did not really accept responsibility or bring any additional resource with it. I will be delighted to take up the invitation to join the all-party group.
We all know the history. Between 1958 and 1962, thalidomide was given to thousands of pregnant women in the UK, supposedly as a simple solution to relieve morning sickness. In what has been called one of the darkest episodes in pharmaceutical research history, however, the drug caused thousands of babies to be born with a range of physical disabilities and medical conditions. It is worth remembering that the 472 thalidomiders alive in the UK today have been through a whole range of difficulties in their lives. They have been affected in a variety of ways, not only due to missing, short or deformed limbs, which is the common perception.
I congratulate the hon. Lady on bringing this matter before hon. Members. In Northern Ireland, there are 18 thalidomide victims, of whom eight are in my constituency and district, so the subject is close to my heart. One of the ladies, Sara Bunting from Newtownards, came to me this week to outline her case, which was to do with not only health but education. Does the hon. Lady feel that any pilot scheme for thalidomide victims must address not only the health issues alone, but education, because in many cases those people did not realise their potential? Such potential, if realised, could have been equal to or perhaps better than that of many in the Chamber.
The hon. Gentleman makes a valid point. This debate is focused on the health grant, but many people, with the right support and resources at an earlier stage and with people to champion their cause, could perhaps have done more to realise their potential. Ministers will want to take that on board to see what can be done in future in relation to the grant.
Many thalidomiders suffered damage to their eyes and ears, facial disfigurement and from damaged or missing internal organs, and a number have brain damage. Some 20% have hearing difficulties or deafness, and 1% are blind. The thalidomiders, who are now aged between 49 and 52, are beginning to show signs of early-onset wear and tear—the kind of symptoms normally expected of people in their 70s, 80s or 90s—and that has to be as a result of putting an unusual and sometimes extreme level of pressure and strain on their already disabled bodies.
The issue of justice is important, and it involves not just the health grant, although that is important, but compensation and other issues that are being pursued elsewhere.
Does the hon. Lady think that the Government should put pressure on the German Grünenthal Group? It said this week:
“we have been silent and we are very sorry for that.”
If its apology is forthcoming, surely it is time for it to deliver compensation. Perhaps the Government will support the thalidomide victims in their campaign for full compensation.
I am sure that any company would listen carefully to the comments and views that MPs are setting out on behalf of their constituents and take account of any message from the Government. I hope that Ministers will join us in calling for additional support and, further to the company’s apology, more compensation. The company must take responsibility for its actions.